Literature DB >> 1563309

Gastrointestinal involvement in L-tryptophan (L-Trp) associated eosinophilia-myalgia syndrome (EMS).

K De Schryver-Kecskemeti1, K W Bennert, G S Cooper, P Yang.   

Abstract

We report a 45-year-old female who had symptomatic gastrointestinal involvement, eosinophils in the cellular infiltrate, and who proved to have L-tryptophan-associated eosinophilia-myalgia syndrome. This case illustrates that gastrointestinal disease can be a major, seemingly primary clinical presentation in this syndrome, and that a drug history, specifically L-tryptophan, needs to be included in the differential diagnosis of "eosinophilic gastroenteritis."

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1563309     DOI： 10.1007/bf01296424

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


  23 in total

1.  Clinical spectrum of the systemic manifestations of the eosinophilia-myalgia syndrome.

Authors:  J Varga; T D Heiman-Patterson; D L Emery; R Griffin; E V Lally; J J Uitto; S A Jimenez
Journal:  Semin Arthritis Rheum       Date:  1990-06       Impact factor: 5.532

2.  Interim guidance on the eosinophilia-myalgia syndrome.

Authors:  E M Kilbourne; L A Swygert; R M Philen; R K Sun; S B Auerbach; L Miller; D E Nelson; H Falk
Journal:  Ann Intern Med       Date:  1990-01-15       Impact factor: 25.391

3.  Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues.

Authors:  N J Talley; R G Shorter; S F Phillips; A R Zinsmeister
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

4.  Eosinophilia-myalgia syndrome and L-tryptophan-containing products--New Mexico, Minnesota, Oregon, and New York, 1989.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1989-11-24       Impact factor: 17.586

5.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

6.  A previously unrecognized subgroup of "eosinophilic gastroenteritis". Association with connective tissue diseases.

Authors:  K DeSchryver-Kecskemeti; R E Clouse
Journal:  Am J Surg Pathol       Date:  1984-03       Impact factor: 6.394

7.  L-tryptophan ingestion associated with eosinophilic fasciitis but not progressive systemic sclerosis.

Authors:  B Freundlich; V P Werth; A H Rook; C R O'Connor; H R Schumacher; J J Leyden; P D Stolley
Journal:  Ann Intern Med       Date:  1990-05-15       Impact factor: 25.391

8.  Effect of intestinal anaphylaxis on gut function in the rat.

Authors:  M H Perdue; M Chung; D G Gall
Journal:  Gastroenterology       Date:  1984-03       Impact factor: 22.682

9.  The gastrointestinal manifestations of scleroderma: pathogenesis and management.

Authors:  S Cohen
Journal:  Gastroenterology       Date:  1980-07       Impact factor: 22.682

10.  Development of diffuse fasciitis with eosinophilia during L-tryptophan treatment: demonstration of elevated type I collagen gene expression in affected tissues. A clinicopathologic study of four patients.

Authors:  J Varga; J Peltonen; J Uitto; S Jimenez
Journal:  Ann Intern Med       Date:  1990-03-01       Impact factor: 25.391
View more
  1 in total

Review 1.  Tryptophan. Current status and future trends for oral administration.

Authors:  L D Kaufman; R M Philen
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.